Relay Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Relay Therapeutics, a new breed of company at the intersection of computation and biotechnology, today announced that Sanjiv Patel, M.D., president and chief executive officer, will present an overview of the company’s business and scientific objectives at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13^th at 12:00 p.m. PT (3:00 p.m. ET).

About Relay Therapeutics
Relay Therapeutics is a new breed of company at the intersection of leading edge experimental and computational approaches focused on making medicines against difficult to drug targets. Relay Tx harnesses the forces of expanding computational power and increasing experimental insights to better understand the dynamic nature of protein motion. The approach has been validated with multiple programs poised to enter the clinic. While the company’s initial focus has been in oncology, Relay Tx’s approach has broad applicability and potential to design transformative medicines across a range of disease areas. Headquartered in Cambridge, Massachusetts, Relay Therapeutics is a private company launched in 2016. To date the company has raised $520M from investors including SoftBank Vision Fund, Third Rock Ventures, Casdin Capital, GV, BVF Partners, EcoR1 Capital, Foresite Capital, Perceptive Advisors, Tavistock Group and an affiliate of D.E. Shaw Research.